Cesar Pena-Rodriguez
Internal Medicine · Garland, TXNPI 1073576435
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $474 and has fallen 67.0% since, to $156 in 2023.
Across 98 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$357
- Boehringer Ingelheim$212
- AstraZeneca$210
- Amgen$209
- Novo Nordisk$124
- Merck$76
- plus $305 from 13 others
What the payments were for
- Food & beverage$1,493100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $357 |
| Boehringer Ingelheim | 12 | $212 |
| AstraZeneca | 14 | $210 |
| Amgen(2 entities) | 14 | $209 |
| Novo Nordisk | 8 | $124 |
| Merck | 5 | $76 |
| Lilly USA, LLC | 3 | $50 |
| Pfizer | 2 | $47 |
| Almatica Pharma LLC | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Optinose US, Inc. | 2 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $16 |
| GSK | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$1,493 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Garland
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.